<p>* All guideline strategies affect adults not previously treated for hypertension only, i.e., “aware/treated/uncontrolled” population not treated.</p><p><sup>†</sup> To convert cost input to Chinese currency, multiply by PPP rate (in this case, 3.52). To convert to $US using the current official exchange rate, multiply by (PPP/exchange rate), for example, 3.52/6.20, or by 5.68.</p><p><sup>§</sup> Less than 2 x China’s GDP per capita.</p><p>Each successive strategy is compared with the prior strategy. Results are in 2015 international dollars and 2015 Chinese RMB. All results reported as cost-saving describe strategies projected to be less costly and more effective than the prior strategy. Ninety-five percent uncertainty intervals were cal...
IMPORTANCE Hypertension is a leading cause of premature death in China, but limited evidence is avai...
Background: Lifestyle and dietary changes reflect an ongoing epidemiological transition in China, wi...
Background Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension...
Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension control in...
The population health effect and cost-effectiveness of implementing intensive blood pressure goals i...
Background: Hypertension and associated chronic diseases impose enormous and growing health and econ...
Background—The World Health Organization aims to reduce mortality from chronic diseases including ca...
The population health effect and cost-effectiveness of implementing intensive blood pressure goals i...
BackgroundOn the basis of the 2014 guidelines for hypertension therapy in the United States, many el...
<p>* WHO CHOICE lowest outpatient visit cost for China</p><p><sup>†</sup> Stage two twice yearly, st...
Objective: Based on the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients...
Hypertension control rates are unacceptably low in China. The present study demonstrates if a custom...
BackgroundThe Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in d...
BackgroundHypertension and associated chronic diseases impose enormous and growing health and econom...
Hypertension is a leading cause of premature death in China, but limited evidence is available on th...
IMPORTANCE Hypertension is a leading cause of premature death in China, but limited evidence is avai...
Background: Lifestyle and dietary changes reflect an ongoing epidemiological transition in China, wi...
Background Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension...
Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension control in...
The population health effect and cost-effectiveness of implementing intensive blood pressure goals i...
Background: Hypertension and associated chronic diseases impose enormous and growing health and econ...
Background—The World Health Organization aims to reduce mortality from chronic diseases including ca...
The population health effect and cost-effectiveness of implementing intensive blood pressure goals i...
BackgroundOn the basis of the 2014 guidelines for hypertension therapy in the United States, many el...
<p>* WHO CHOICE lowest outpatient visit cost for China</p><p><sup>†</sup> Stage two twice yearly, st...
Objective: Based on the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients...
Hypertension control rates are unacceptably low in China. The present study demonstrates if a custom...
BackgroundThe Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in d...
BackgroundHypertension and associated chronic diseases impose enormous and growing health and econom...
Hypertension is a leading cause of premature death in China, but limited evidence is available on th...
IMPORTANCE Hypertension is a leading cause of premature death in China, but limited evidence is avai...
Background: Lifestyle and dietary changes reflect an ongoing epidemiological transition in China, wi...
Background Hypertension is China’s leading cardiovascular disease risk factor. Improved hypertension...